Showing results (171-180 of 514) with videos related to
Sort By:
Pageof 52
Pediatric Blood & Cancer|May 16, 2022
Molecular pathological insights reveal a high number of unfavorable risk patients among children treated for medulloblastoma and CNS-PNET in Oslo 2005-2017Pitt Niehusmann, Einar Stensvold, Henning Leske, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 1, 2011
Curative treatment for central nervous system medulloepithelioma despite residual disease after resection. Report of two cases treated according to the GPHO Protocol HIT 2000 and review of the literatureKlaus Müller, Isabella Zwiener, Helmut Welker, et al.International Journal of Cancer|December 6, 2011
Predictive impact of MGMT promoter methylation in glioblastoma of the elderlyGuido Reifenberger, Bettina Hentschel, Jörg Felsberg, et al.Endocrine Connections|October 25, 2023
Perinatally diagnosed congenital craniopharyngiomas in the KRANIOPHARYNGEOM trialsJulia Beckhaus, Svenja Boekhoff, Katrin Scheinemann, et al.International Journal of Cancer|July 9, 2004
Allelic loss but absence of mutations in the polyspecific transporter gene BWR1A on 11p15.5 in hepatoblastomaSteffen Albrecht, Wolfgang Hartmann, Farzad Houshdaran, et al.Journal of Neuro-Oncology|August 10, 2010
High dose methotrexate for pediatric high grade glioma: results of the HIT-GBM-D pilot studyJohannes E Wolff, Rolf-Dieter Kortmann, Birte Wolff, et al.European Journal of Endocrinology|April 15, 2011
Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-upHermann L Müller, Ursel Gebhardt, Carmen Teske, et al.Cancer Immunology, Immunotherapy : CII|January 14, 2009
Ablation of T cell immunity differentially influences tumor risk in inbred BD rat strainsJudith A M Marx, Ansgar J Röhrborn, Bernd U Koelsch, et al.Acta Neuropathologica Communications|May 22, 2019
H3F3A-G34R mutant high grade neuroepithelial neoplasms with glial and dysplastic ganglion cell componentsFelipe Andreiuolo, Tomo Lisner, Jozef Zlocha, et al.Neuro-Oncology|August 21, 2014
TERT promoter mutations: a novel independent prognostic factor in primary glioblastomasMatthias Simon, Ismail Hosen, Konstantinos Gousias, et al.Pageof 52